| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
CRC Institute for Cancer Studies, University of Birmingham, Birmingham, United Kingdom; and
William S. Rowe Division of Rheumatology, Children’s Hospital Medical Center, Cincinnati, OH 45229
HLA-B27-restricted CTL responses to EBV are principally directed against two of the EBV nuclear Ags, EBNAs 3B and 3C. We have previously described a target epitope derived from EBNA 3C (residues 258–266, sequence RRIYDLIEL) that is immunodominant in the context of at least three different B27 subtypes, including B*2705 and B*2702. In this study, we show that this peptide binds well to B*2705 and B*2702 in a cell surface binding assay, and that the two B27:peptide complexes are relatively stable, with t1/2 of 20 and 37 h, respectively. We now identify another B27-restricted epitope derived from EBNA 3B (residues 243–253, sequence RRARSLSAERY), which again accords well with the B*2705/B*2702 consensus motifs, having an arginine residue at position 2 and a tyrosine residue at the carboxyl terminus. In this case, five of five B*2702-positive donors respond to the epitope, whereas there was no response in any B*2705-positive donor studied. This peptide binds at least as well to B*2705 as to its restriction element B*2702; however, the two class I:peptide complexes show marked differences in stability, with t1/2 of 9 and 42 h, respectively. Thus, the stability of B27:peptide complexes can vary markedly between different B27 subtypes in ways that may not be apparent from cell surface binding assays and cannot be predicted from currently known peptide consensus motifs, yet which may critically influence CTL epitope choice.
This article has been cited by other articles:
|
|
 |
|
  L. Sesma, B. Galocha, M. Vazquez, A. W. Purcell, M. Marcilla, J. McCluskey, and J. A. L. de Castro Qualitative and Quantitative Differences in Peptides Bound to HLA-B27 in the Presence of Mouse versus Human Tapasin Define a Role for Tapasin as a Size-Dependent Peptide Editor J. Immunol., June 15, 2005; 174(12): 7833 - 7844. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. I. Webb, M. A. Dunstone, W. Chen, M.-I. Aguilar, Q. Chen, H. Jackson, L. Chang, L. Kjer-Nielsen, T. Beddoe, J. McCluskey, et al. Functional and Structural Characteristics of NY-ESO-1-related HLA A2-restricted Epitopes and the Design of a Novel Immunogenic Analogue J. Biol. Chem., May 28, 2004; 279(22): 23438 - 23446. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Midgley, A. I. Bell, Q. Y. Yao, D. Croom-Carter, A. D. Hislop, B. M. Whitney, A. T. C. Chan, P. J. Johnson, and A. B. Rickinson HLA-A11-Restricted Epitope Polymorphism among Epstein-Barr Virus Strains in the Highly HLA-A11-Positive Chinese Population: Incidence and Immunogenicity of Variant Epitope Sequences J. Virol., November 1, 2003; 77(21): 11507 - 11516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Malik, P. Klimovitsky, L.-W. Deng, J. E. Boyson, and J. L. Strominger Uniquely Conformed Peptide-Containing {beta}2-Microglobulin- Free Heavy Chains of HLA-B2705 on the Cell Surface J. Immunol., October 15, 2002; 169(8): 4379 - 4387. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. W. Purcell, J. J. Gorman, M. Garcia-Peydro, A. Paradela, S. R. Burrows, G. H. Talbo, N. Laham, C. A. Peh, E. C. Reynolds, J. A. Lopez de Castro, et al. Quantitative and Qualitative Influences of Tapasin on the Class I Peptide Repertoire J. Immunol., January 15, 2001; 166(2): 1016 - 1027. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. L. Crotzer, R. E. Christian, J. M. Brooks, J. Shabanowitz, R. E. Settlage, J. A. Marto, F. M. White, A. B. Rickinson, D. F. Hunt, and V. H. Engelhard Immunodominance Among EBV-Derived Epitopes Restricted by HLA-B27 Does Not Correlate with Epitope Abundance in EBV-Transformed B-Lymphoblastoid Cell Lines J. Immunol., June 15, 2000; 164(12): 6120 - 6129. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q.-J. Zhang, S. S. Chen, C.-A. Saari, M. G. Massuci, F. Tufaro, and W. A. Jefferies Evidence of Selective Processing of Immunodominant Epitopes in Virally Infected Cells J. Immunol., May 1, 2000; 164(9): 4513 - 4521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Brooks, D. S. G. Croom-Carter, A. M. Leese, R. J. Tierney, G. Habeshaw, and A. B. Rickinson Cytotoxic T-Lymphocyte Responses to a Polymorphic Epstein-Barr Virus Epitope Identify Healthy Carriers with Coresident Viral Strains J. Virol., February 15, 2000; 74(4): 1801 - 1809. [Abstract] [Full Text]
|
|
|
|
|
|
A. Paradela, I. Alvarez, M. Garcia-Peydro, L. Sesma, M. Ramos, J. Vazquez, and J. A. Lopez de Castro Limited Diversity of Peptides Related to an Alloreactive T Cell Epitope in the HLA-B27-Bound Peptide Repertoire Results from Restrictions at Multiple Steps Along the Processing-Loading Pathway J. Immunol., January 1, 2000; 164(1): 329 - 337. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Mear, K. L. Schreiber, C. Munz, X. Zhu, S. Stevanovic, H.-G. Rammensee, S. L. Rowland-Jones, and R. A. Colbert Misfolding of HLA-B27 as a Result of Its B Pocket Suggests a Novel Mechanism for Its Role in Susceptibility to Spondyloarthropathies J. Immunol., December 15, 1999; 163(12): 6665 - 6670. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Garcia-Peydro, M. Marti, and J. A. Lopez de Castro High T Cell Epitope Sharing Between Two HLA-B27 Subtypes (B*2705 and B*2709) Differentially Associated to Ankylosing Spondylitis J. Immunol., August 15, 1999; 163(4): 2299 - 2305. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Dedier, S. Reinelt, T. Reitinger, G. Folkers, and D. Rognan Thermodynamic Stability of HLA-B*2705{middle dot}Peptide Complexes. EFFECT OF PEPTIDE AND MAJOR HISTOCOMPATIBILITY COMPLEX PROTEIN MUTATIONS J. Biol. Chem., August 25, 2000; 275(35): 27055 - 27061. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
